Tag: openai_revenue_forecast
-
Drugmakers Say GLP-1 Weight-Loss Drugs Show Signs of Slowing Biological Aging
Eli Lilly and Novo Nordisk report a roughly two- to three-year reduction in biological age, while researchers continue to probe side effects including hair loss, nail disorders and a disputed vision-loss link.
Science & TechnologyHealthBusinessPolitics and GovernmentArtificial IntelligenceMedical ScienceEnergyComputers and InternetMilitaryLegalUSASocial IssuesPharmaceuticalsEnvironmentClimate ChangeEconomy MIT Technology ReviewAI refusalGLP-1 weight-loss drugsEnvision EnergyAnthropic ClaudeOpenAI revenue forecastMITsciencetechnologyGLP-1 drugsbiological ageEli LillyNovo Nordiskweight lossWorld Health Organizationchildhood obesityOpenAIMistralGoogle data center Finlandbiological agingaging clockssemaglutide